Global cardiovascular and renal outcomes of reduced GFR

197Citations
Citations of this article
342Readers
Mendeley users who have this article in their library.

Abstract

The burden of premature death and health loss from ESRD is well described. Less is known regarding the burden of cardiovascular disease attributable to reduced GFR. We estimated the prevalence of reduced GFR categories 3, 4, and 5 (not on RRT) for 188 countries at six time points from1990 to 2013. Relative risks of cardiovascular outcomes by three categories of reducedGFRwere calculated by pooled randomeffects meta-analysis. Results are presented as deaths for outcomes of cardiovascular disease and ESRD and as disability-adjusted life years for outcomes of cardiovascular disease,GFR categories 3, 4, and 5, and ESRD. In 2013, reduced GFR was associated with 4% of deaths worldwide, or 2.2 million deaths (95%uncertainty interval [95%UI], 2.0 to 2.4million).More than half of these attributable deathswere cardiovascular deaths (1.2million; 95%UI, 1.1 to 1.4million), whereas 0.96million (95%UI, 0.81 to 1.0 million) were ESRD-related deaths. Compared with metabolic risk factors, reduced GFR ranked below high systolic BP, high body mass index, and high fasting plasma glucose, and similarly with high total cholesterol as a risk factor for disability-adjusted life years in both developed and developing world regions. In conclusion, by 2013, cardiovascular deaths attributed to reduced GFR outnumbered ESRD deaths throughout the world. Studies are needed to evaluate the benefit of early detection of CKD and treatment to decrease these deaths.

References Powered by Scopus

The Environment and Disease: Association or Causation?

8092Citations
N/AReaders
Get full text

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

6259Citations
N/AReaders
Get full text

Prevalence of chronic kidney disease in the United States

4165Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

4202Citations
N/AReaders
Get full text

Chronic kidney disease

800Citations
N/AReaders
Get full text

Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016

759Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Thomas, B., Matsushita, K., Abate, K. H., Al-Aly, Z., Ärnlöv, J., Asayama, K., … Vos, T. (2017). Global cardiovascular and renal outcomes of reduced GFR. Journal of the American Society of Nephrology, 28(7), 2167–2179. https://doi.org/10.1681/ASN.2016050562

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 72

42%

Researcher 47

28%

Professor / Associate Prof. 38

22%

Lecturer / Post doc 13

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 107

71%

Biochemistry, Genetics and Molecular Bi... 20

13%

Nursing and Health Professions 16

11%

Economics, Econometrics and Finance 8

5%

Article Metrics

Tooltip
Mentions
News Mentions: 11
Social Media
Shares, Likes & Comments: 12

Save time finding and organizing research with Mendeley

Sign up for free